|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Vaginal burning, itching, discharge, or other irritation not present before therapy |
|
Hypersensitivity |
|
Abdominal or stomach cramps or pain |
|
burning or irritation of penis of sexual partner |
|
headache |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
Antifungal (vaginal)-Nonpregnant patients: Intravaginal, 500 mg as a single dose, preferably at bedtime ; 200 mg once a day, preferably at bedtime, for three consecutive days ; or 100 mg once a day, preferably at bedtime, for six or seven consecutive days.
Pregnant patients: Intravaginal, 100 mg once a day, preferably at bedtime, for seven consecutive days.
Note: The three-day regimen is not effective in pregnant women .
In severe vulvovaginal candidiasis, single-dose treatment with clotrimazole 500-mg vaginal tablets may not be effective. Longer treatment with the 100- or 200-mg vaginal tablets or vaginal cream is recommended. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Children up to 12 years of age: Safety and efficacy have not been established .
|
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|